Nalaganje...
Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
Imipenem-cilastatin was given in doses of 1 g intravenously every 6 h to 31 patients. Twenty-five patients, with 27 infections, were clinically evaluable and received 20 to 210 g of imipenem for a duration of 5 to 56 days (average 16.3 days). Infections included seven cases of osteomyelitis, seven o...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
1985
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180145/ https://ncbi.nlm.nih.gov/pubmed/3860187 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|